Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review
<p>Abstract</p> <p>Background</p> <p>Prostate specific antigen (PSA) testing is widely used, but guidelines on follow-up are unclear.</p> <p>Methods</p> <p>We performed a systematic review of the literature to determine follow-up policy after PSA...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | BMC Family Practice |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2296/13/100 |
id |
doaj-07981148fbe3462789c6de47ff0e4d6c |
---|---|
record_format |
Article |
spelling |
doaj-07981148fbe3462789c6de47ff0e4d6c2020-11-25T03:40:10ZengBMCBMC Family Practice1471-22962012-10-0113110010.1186/1471-2296-13-100Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic reviewVan der Meer SaskiaLöwik Sabine AMHirdes Willem HNijman Rien MVan der Meer KlaasHoekstra-Weebers Josette EHMBlanker Marco H<p>Abstract</p> <p>Background</p> <p>Prostate specific antigen (PSA) testing is widely used, but guidelines on follow-up are unclear.</p> <p>Methods</p> <p>We performed a systematic review of the literature to determine follow-up policy after PSA testing by general practitioners (GPs) and non-urologic hospitalists, the use of a cut-off value for this policy, the reasons for repeating a PSA test after an initial normal result, the existence of a general cut-off value below which a PSA result is considered normal, and the time frame for repeating a test.</p> <p><it>Data sources</it>. MEDLINE, Embase, PsychInfo and the Cochrane library from January 1950 until May 2011.</p> <p><it>Study eligibility criteria</it>. Studies describing follow-up policy by GPs or non-urologic hospitalists after a primary PSA test, excluding urologists and patients with prostate cancer. Studies written in Dutch, English, French, German, Italian or Spanish were included. Excluded were studies describing follow-up policy by urologists and follow-up of patients with prostate cancer. The quality of each study was structurally assessed.</p> <p>Results</p> <p>Fifteen articles met the inclusion criteria. Three studies were of high quality. Follow-up differed greatly both after a normal and an abnormal PSA test result. Only one study described the reasons for not performing follow-up after an abnormal PSA result.</p> <p>Conclusions</p> <p>Based on the available literature, we cannot adequately assess physicians’ follow-up policy after a primary PSA test. Follow-up after a normal or raised PSA test by GPs and non-urologic hospitalists seems to a large extent not in accordance with the guidelines.</p> http://www.biomedcentral.com/1471-2296/13/100Prostate specific antigenPSAFollow-upGeneral practitionersNon-urologic hospitalistsGuidelinesSystematic review |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Van der Meer Saskia Löwik Sabine AM Hirdes Willem H Nijman Rien M Van der Meer Klaas Hoekstra-Weebers Josette EHM Blanker Marco H |
spellingShingle |
Van der Meer Saskia Löwik Sabine AM Hirdes Willem H Nijman Rien M Van der Meer Klaas Hoekstra-Weebers Josette EHM Blanker Marco H Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review BMC Family Practice Prostate specific antigen PSA Follow-up General practitioners Non-urologic hospitalists Guidelines Systematic review |
author_facet |
Van der Meer Saskia Löwik Sabine AM Hirdes Willem H Nijman Rien M Van der Meer Klaas Hoekstra-Weebers Josette EHM Blanker Marco H |
author_sort |
Van der Meer Saskia |
title |
Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review |
title_short |
Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review |
title_full |
Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review |
title_fullStr |
Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review |
title_full_unstemmed |
Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review |
title_sort |
prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review |
publisher |
BMC |
series |
BMC Family Practice |
issn |
1471-2296 |
publishDate |
2012-10-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Prostate specific antigen (PSA) testing is widely used, but guidelines on follow-up are unclear.</p> <p>Methods</p> <p>We performed a systematic review of the literature to determine follow-up policy after PSA testing by general practitioners (GPs) and non-urologic hospitalists, the use of a cut-off value for this policy, the reasons for repeating a PSA test after an initial normal result, the existence of a general cut-off value below which a PSA result is considered normal, and the time frame for repeating a test.</p> <p><it>Data sources</it>. MEDLINE, Embase, PsychInfo and the Cochrane library from January 1950 until May 2011.</p> <p><it>Study eligibility criteria</it>. Studies describing follow-up policy by GPs or non-urologic hospitalists after a primary PSA test, excluding urologists and patients with prostate cancer. Studies written in Dutch, English, French, German, Italian or Spanish were included. Excluded were studies describing follow-up policy by urologists and follow-up of patients with prostate cancer. The quality of each study was structurally assessed.</p> <p>Results</p> <p>Fifteen articles met the inclusion criteria. Three studies were of high quality. Follow-up differed greatly both after a normal and an abnormal PSA test result. Only one study described the reasons for not performing follow-up after an abnormal PSA result.</p> <p>Conclusions</p> <p>Based on the available literature, we cannot adequately assess physicians’ follow-up policy after a primary PSA test. Follow-up after a normal or raised PSA test by GPs and non-urologic hospitalists seems to a large extent not in accordance with the guidelines.</p> |
topic |
Prostate specific antigen PSA Follow-up General practitioners Non-urologic hospitalists Guidelines Systematic review |
url |
http://www.biomedcentral.com/1471-2296/13/100 |
work_keys_str_mv |
AT vandermeersaskia prostatespecificantigentestingpolicyworldwidevariesgreatlyandseemsnottobeinaccordancewithguidelinesasystematicreview AT lowiksabineam prostatespecificantigentestingpolicyworldwidevariesgreatlyandseemsnottobeinaccordancewithguidelinesasystematicreview AT hirdeswillemh prostatespecificantigentestingpolicyworldwidevariesgreatlyandseemsnottobeinaccordancewithguidelinesasystematicreview AT nijmanrienm prostatespecificantigentestingpolicyworldwidevariesgreatlyandseemsnottobeinaccordancewithguidelinesasystematicreview AT vandermeerklaas prostatespecificantigentestingpolicyworldwidevariesgreatlyandseemsnottobeinaccordancewithguidelinesasystematicreview AT hoekstraweebersjosetteehm prostatespecificantigentestingpolicyworldwidevariesgreatlyandseemsnottobeinaccordancewithguidelinesasystematicreview AT blankermarcoh prostatespecificantigentestingpolicyworldwidevariesgreatlyandseemsnottobeinaccordancewithguidelinesasystematicreview |
_version_ |
1724535901488414720 |